Related content

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

By Konjević Gordana   Mirjačić Martinović Katarina   Vuletić Ana   Jović Viktor   Jurisić Vladimir   Babović Nada   Spužić Ivan  

Clinical and Experimental Metastasis, Vol. 24, Iss. 1, 2007-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Bispecific antiCD3 x antiHER2 antibody mediates T cell cytolytic activity to HER2positive colorectal cancer in vitro and in vivo

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2446-2454

Spandidos Publications

Access to resources Recommend Favorite

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-CELL chronic lymphocytic leukemia

By Cavalli-Björkman Nina   Ösby Eva   Lundin Jeanette   Kalin Mats   Österborg Anders   Gruber Astrid  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 277-280

Humana Press, Inc

Access to resources Recommend Favorite

Anti-CD20 antibody induces the improvement of cytokine-induced killer cell activity via the STAT and MAPK/ERK signaling pathways

By            

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1215-1222

Spandidos Publications

Access to resources Recommend Favorite

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

By Sebastian Martin   Passlick Bernward   Friccius-Quecke Hilke   Jäger Michael   Lindhofer Horst   Kanniess Frank   Wiewrodt Rainer   Thiel Eckhard   Buhl Roland   Schmittel Alexander  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1637-1644

Springer Publishing Company

Access to resources Recommend Favorite